Results 1 to 10 of about 31,865 (111)

Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions

open access: yesFrontiers in Immunology, 2021
Acral and mucosal melanomas are extremely rare in Caucasians; however, they are the predominant melanoma subtypes in Asians and other non-Caucasian populations.
Lili Mao, Jun Guo, Lu Si
exaly   +3 more sources

Talimogene Laherparepvec treatment for mucosal melanoma with metastatic lymph node metastasis: case report [PDF]

open access: yesFrontiers in Oncology
Mucosal melanoma is a rare and aggressive subtype of melanoma, accounting for approximately 1% of all melanoma cases. Of those, only 4% occur primarily in the vagina.
Arnar B. Ingason   +4 more
doaj   +2 more sources

Sinonasal mucosal melanoma in an elderly patient: a case report [PDF]

open access: yesJournal of Medical Case Reports
Background Mucosal melanoma is an aggressive Malignancy arising from melanocytes in mucosal membranes. Sinonasal mucosal melanoma accounts for approximately 1% of all melanomas and 4% of all sinonasal tumors.
Edwin Liwa   +13 more
doaj   +2 more sources

Real-world study of SHR-1210 plus apatinib in the treatment of BRAF-negative mucosal melanoma: efficacy, safety and implications of precision medicine [PDF]

open access: yesFrontiers in Immunology
BackgroundMucosal melanomas arise from melanocytes in mucosal tissues, and it’s usually detected at a late stage owing to its anatomic location. Advances in immunotherapies have proved to be promising therapeutic approaches for advanced mucosal melanoma ...
Yong Zhang   +10 more
doaj   +2 more sources

Case Report: Surgery combined with targeted therapy for metastatic anorectal malignant mucosal melanoma [PDF]

open access: yesFrontiers in Oncology
BackgroundAnorectal mucosal melanoma is a rare tumor with a poor prognosis. Timely diagnosis and treatment are essential for improving patient survival. Currently, there is no standardized treatment approach for this disease.
Yadong Yao   +8 more
doaj   +2 more sources

Combatting Mucosal Melanoma: Recent Advances and Future Perspectives

open access: yesMelanoma Management, 2018
Mucosal melanomas are a rare subtype of melanoma and are associated with a particularly poor prognosis. Due to the rarity of the diagnosis, and the pace with which the management of cutaneous melanoma has evolved over recent years, there is little good ...
Miranda Payne
exaly   +3 more sources

Multidisciplinary approach and treatment of acral and mucosal melanoma

open access: yesFrontiers in Oncology
Acral and mucosal melanoma are uncommon variants of melanoma. Acral melanoma has an age-adjusted incidence of approximately 1.8 cases per million individuals per year, accounting for about 2% to 3% of all melanoma cases.
TERESA Amaral, Amaral TERESA
exaly   +3 more sources

Case Report: Trastuzumab deruxtecan plus toripalimab in ERBB2-amplified cervical mucosal melanoma [PDF]

open access: yesFrontiers in Oncology
Cervical mucosal melanoma is a rare, aggressive malignancy with poor prognosis due to delayed diagnosis and limited treatment efficacy. Current therapies, including immune checkpoint inhibitors (e.g., anti-PD-1 agents), chemotherapy, and targeted ...
Xiao-Xia Wang, Min-Xin Wang, Chao Sui
doaj   +2 more sources

Genetic Characteristics of Cutaneous, Acral, and Mucosal Melanoma in Japan [PDF]

open access: yesCancer Medicine
Background Acral and mucosal melanomas are more prevalent in Asians than in Caucasians, unlike cutaneous melanomas, which are predominant in Caucasians.
Tokimasa Hida   +11 more
doaj   +2 more sources

Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade

open access: yesCancer Medicine, 2021
Mucosal melanoma is a rare form of melanoma which arises from melanocytes in the mucosal membranes and can be effectively treated with immune checkpoint blockade (ICB).
Elizabeth I. Buchbinder   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy